{"hands_on_practices": [{"introduction": "The concepts of dominance and recessiveness are cornerstones of Mendelian genetics, yet they are often treated as abstract rules. This exercise challenges you to derive these concepts from first principles, grounding them in the molecular biology of gene expression. By modeling enzyme dosage, you will demonstrate how dominance is not an intrinsic property of an allele but an emergent feature of the phenotype, depending on biochemical thresholds and reaction kinetics. This practice is fundamental to understanding how a genotype translates into a clinically observable trait. [@problem_id:5021767]", "problem": "Consider a single autosomal locus with two alleles, $A$ and $a$, in a pharmacogene relevant to drug metabolism. The allele $A$ encodes a functional enzyme, whereas the allele $a$ is a loss-of-function variant. Two individuals, each with genotype $Aa$, mate. Assume the following fundamental bases: the law of segregation (each parent forms gametes carrying allele $A$ or allele $a$ with equal probability), diploid inheritance with random union of gametes, and the Central Dogma of molecular biology (deoxyribonucleic acid (DNA) is transcribed into messenger ribonucleic acid (mRNA), which is translated into protein). Assume that each $A$ allele produces $1$ unit of enzyme activity and each $a$ allele produces $0$ units, so total activity equals the sum of allele contributions.\n\nDefine two phenotype classification schemes grounded in molecular dosage and biochemistry:\n- Complete dominance: classify an individual as “metabolically normal” if the total enzyme activity is greater than or equal to $1$ unit, and “metabolically deficient” otherwise. This threshold represents a biochemical sufficiency criterion for safe drug clearance.\n- Codominance: classify individuals into three ordered activity classes based on total enzyme activity: “high” for $2$ units, “intermediate” for $1$ unit, and “low” for $0$ units.\n\nStarting only from the law of segregation and random union of gametes, derive the expected genotype frequencies among the offspring of the $Aa \\times Aa$ cross, then map these genotypes to the above phenotype classes using the stated dosage model. Explain why the apparent dominance arises as a phenotype-level construct emergent from molecular dosage and reaction kinetics, rather than from altered transmission rules, by referencing how enzymatic flux depends on enzyme concentration.\n\nExpress all frequencies as exact fractions (not percentages). Provide your final answer as a single row matrix, ordered as follows:\n$$(AA,\\ Aa,\\ aa,\\ \\text{complete-dominance normal},\\ \\text{complete-dominance deficient},\\ \\text{codominance high},\\ \\text{codominance intermediate},\\ \\text{codominance low}).$$\nNo rounding is required.", "solution": "The problem has been validated and is deemed valid. It is scientifically grounded, well-posed, and objective, resting on fundamental principles of Mendelian genetics, molecular biology, and pharmacogenetics. All necessary information is provided for a unique solution.\n\nThe problem requires the derivation of expected genotype and phenotype frequencies from a monohybrid cross and an explanation of the concept of dominance from a biochemical perspective.\n\nFirst, we determine the expected genotype frequencies in the offspring of an $Aa \\times Aa$ cross. According to the law of segregation, each heterozygous parent (genotype $Aa$) produces two types of gametes, one carrying allele $A$ and the other carrying allele $a$, with equal probability. Let $P(A)$ be the probability of a gamete carrying allele $A$, and $P(a)$ be the probability of a gamete carrying allele $a$. For a heterozygous parent, $P(A) = \\frac{1}{2}$ and $P(a) = \\frac{1}{2}$.\n\nAssuming random union of gametes, we can use a Punnett square to determine the genotypes of the offspring.\n\nThe probability of an offspring having the genotype $AA$ is the product of the probabilities of receiving an $A$ gamete from each parent:\n$$P(AA) = P(A)_{\\text{parent1}} \\times P(A)_{\\text{parent2}} = \\frac{1}{2} \\times \\frac{1}{2} = \\frac{1}{4}$$\n\nThe probability of an offspring having the genotype $aa$ is the product of the probabilities of receiving an $a$ gamete from each parent:\n$$P(aa) = P(a)_{\\text{parent1}} \\times P(a)_{\\text{parent2}} = \\frac{1}{2} \\times \\frac{1}{2} = \\frac{1}{4}$$\n\nThe probability of an offspring having the heterozygous genotype $Aa$ can occur in two ways: receiving $A$ from parent $1$ and $a$ from parent $2$, or receiving $a$ from parent $1$ and $A$ from parent $2$.\n$$P(Aa) = (P(A)_{\\text{parent1}} \\times P(a)_{\\text{parent2}}) + (P(a)_{\\text{parent1}} \\times P(A)_{\\text{parent2}}) = \\left(\\frac{1}{2} \\times \\frac{1}{2}\\right) + \\left(\\frac{1}{2} \\times \\frac{1}{2}\\right) = \\frac{1}{4} + \\frac{1}{4} = \\frac{1}{2}$$\nThe sum of frequencies must be $1$: $P(AA) + P(Aa) + P(aa) = \\frac{1}{4} + \\frac{1}{2} + \\frac{1}{4} = 1$.\nThe expected genotypic ratio is $1(AA):2(Aa):1(aa)$, with corresponding frequencies of $\\frac{1}{4}$, $\\frac{1}{2}$, and $\\frac{1}{4}$.\n\nNext, we map these genotypes to phenotypes based on the provided dosage model and classification schemes. The dosage model states that an $A$ allele contributes $1$ unit of enzyme activity and an $a$ allele contributes $0$ units.\n\nThe total enzyme activity for each genotype is:\n- Genotype $AA$: $1 + 1 = 2$ units of activity.\n- Genotype $Aa$: $1 + 0 = 1$ unit of activity.\n- Genotype $aa$: $0 + 0 = 0$ units of activity.\n\nNow, we apply the two phenotype classification schemes.\n\n1.  **Complete Dominance Scheme**:\n    - \"Metabolically normal\" is defined as enzyme activity $\\ge 1$ unit.\n    - \"Metabolically deficient\" is defined as enzyme activity $ 1$ unit.\n    - Genotype $AA$ (activity $2$): $2 \\ge 1$, so phenotype is \"metabolically normal\".\n    - Genotype $Aa$ (activity $1$): $1 \\ge 1$, so phenotype is \"metabolically normal\".\n    - Genotype $aa$ (activity $0$): $0  1$, so phenotype is \"metabolically deficient\".\n\n    The frequency of the \"metabolically normal\" phenotype is the sum of the frequencies of the genotypes that produce it:\n    $$P(\\text{normal}) = P(AA) + P(Aa) = \\frac{1}{4} + \\frac{1}{2} = \\frac{3}{4}$$\n    The frequency of the \"metabolically deficient\" phenotype is the frequency of the genotype that produces it:\n    $$P(\\text{deficient}) = P(aa) = \\frac{1}{4}$$\n\n2.  **Codominance Scheme**:\n    - \"High\" activity is $2$ units.\n    - \"Intermediate\" activity is $1$ unit.\n    - \"Low\" activity is $0$ units.\n    - Genotype $AA$ (activity $2$) maps to the \"high\" phenotype. Frequency: $P(\\text{high}) = P(AA) = \\frac{1}{4}$.\n    - Genotype $Aa$ (activity $1$) maps to the \"intermediate\" phenotype. Frequency: $P(\\text{intermediate}) = P(Aa) = \\frac{1}{2}$.\n    - Genotype $aa$ (activity $0$) maps to the \"low\" phenotype. Frequency: $P(\\text{low}) = P(aa) = \\frac{1}{4}$.\n\nFinally, the explanation of emergent dominance. Dominance is not an intrinsic property of an allele nor does it alter the rules of allele transmission, which remain strictly Mendelian ($1:2:1$ genotypic ratio). Instead, dominance emerges at the level of the phenotype as a consequence of the relationship between gene dose (enzyme concentration) and metabolic flux (the rate of the biochemical reaction catalyzed by the enzyme).\n\nThis relationship is typically nonlinear and is often described by the Michaelis-Menten equation: $V = \\frac{V_{max} [S]}{K_M + [S]}$, where the reaction velocity $V$ (flux) depends on substrate concentration $[S]$ and the maximum velocity $V_{max}$. The term $V_{max}$ is directly proportional to the total enzyme concentration, $[E_{total}]$. Thus, $V_{max} = k_{cat}[E_{total}]$.\n\n- For genotype $aa$, $[E_{total}] = 0$, so $V_{max} = 0$ and the flux is $0$. This results in the \"metabolically deficient\" phenotype.\n- For genotype $Aa$, the enzyme concentration is half that of a homozygous normal individual. Let's say $[E_{total}]_{Aa} = E_{1}$. This generates a flux $V_{Aa}$.\n- For genotype $AA$, the enzyme concentration is twice that of a heterozygote, $[E_{total}]_{AA} = 2 E_{1}$. This generates a flux $V_{AA}$.\n\nThe \"complete dominance\" phenotype classification imposes a threshold. If the flux $V_{Aa}$ produced by the heterozygote is sufficient to meet the physiological demand (i.e., $V_{Aa}$ is greater than or equal to some threshold flux $V_{threshold}$ required for a \"normal\" classification), then the $Aa$ individual is phenotypically normal. This phenomenon is known as haplosufficiency. The $AA$ individual will produce a higher flux, $V_{AA} > V_{Aa}$, but if both fluxes are above the classification threshold ($V_{AA} > V_{Aa} \\ge V_{threshold}$), both genotypes $AA$ and $Aa$ are grouped into the same \"normal\" phenotypic category. The phenotypic distinction between $AA$ and $Aa$ is masked by the threshold-based classification, creating the appearance of dominance. The codominant classification, by contrast, resolves these differences by assigning distinct phenotypic categories that directly correspond to the underlying gene dosage ($2$ units, $1$ unit, $0$ units), thus reflecting the molecular reality without a superimposed functional threshold.\n\nThe final values requested are the frequencies of the genotypes followed by the frequencies of the phenotypes under both schemes.\n- Genotype frequencies: $P(AA) = \\frac{1}{4}$, $P(Aa) = \\frac{1}{2}$, $P(aa) = \\frac{1}{4}$.\n- Complete dominance phenotype frequencies: $P(\\text{normal}) = \\frac{3}{4}$, $P(\\text{deficient}) = \\frac{1}{4}$.\n- Codominance phenotype frequencies: $P(\\text{high}) = \\frac{1}{4}$, $P(\\text{intermediate}) = \\frac{1}{2}$, $P(\\text{low}) = \\frac{1}{4}$.\nThe ordered matrix is constructed from these values.", "answer": "$$\\boxed{\\begin{pmatrix} \\frac{1}{4}  \\frac{1}{2}  \\frac{1}{4}  \\frac{3}{4}  \\frac{1}{4}  \\frac{1}{4}  \\frac{1}{2}  \\frac{1}{4} \\end{pmatrix}}$$", "id": "5021767"}, {"introduction": "After establishing the link between genotype and phenotype, a central task in medical genetics is to locate the responsible gene on the vast map of the human genome. This practice introduces you to the statistical foundation of classical gene mapping: linkage analysis. You will calculate the maximum-likelihood estimate of the recombination fraction and the corresponding logarithm of odds (LOD) score, the very metrics that enabled the discovery of countless disease genes, providing a quantitative framework for evaluating evidence of genetic linkage. [@problem_id:5021743]", "problem": "A translational genetics team is mapping a putative autosomal dominant variant that segregates with a severe, fully penetrant monogenic adverse drug reaction. In a large multiplex pedigree, a single highly polymorphic short tandem repeat marker has been genotyped and is known to be fully informative with phase established. Across all informative meioses in the pedigree, the team observes $18$ nonrecombinant transmissions and $2$ recombinant transmissions between the disease locus and the marker. Assume the following: Mendelian segregation holds, meioses are independent, there is no crossover interference within the interval considered, the recombination fraction $\\theta$ is the same in males and females, and there is no genotyping error or phenocopy.\n\nStarting only from the definition of the recombination fraction $\\theta$ as the probability of a recombinant gamete in a single meiosis and the likelihood-based framework that compares linkage models to the no-linkage model (which corresponds to $\\theta = 0.5$), derive the maximum-likelihood estimate $\\hat{\\theta}$ for the recombination fraction and the corresponding logarithm of odds (LOD) score $Z(\\hat{\\theta})$, where $Z(\\theta)$ is the base-$10$ logarithm of the ratio of the likelihood under $\\theta$ to the likelihood under $\\theta = 0.5$. Round your final numeric answers to four significant figures. Express $\\hat{\\theta}$ and $Z(\\hat{\\theta})$ as decimals without a percentage sign. In addition, explain, in words, how to interpret the conventional thresholds $Z \\ge 3$ and $Z \\le -2$ in the context of linkage evidence for this trait-marker pair.", "solution": "The fundamental base is the definition that the recombination fraction $\\theta$ is the probability that a meiosis produces a recombinant gamete with respect to the disease locus and the marker. Under Mendelian segregation with independent meioses and without interference, the sequence of recombinant versus nonrecombinant transmissions across $n$ informative meioses can be modeled as independent Bernoulli trials with probability $\\theta$ for a recombinant and probability $1 - \\theta$ for a nonrecombinant.\n\nLet $R$ denote the number of observed recombinants and $NR$ denote the number of observed nonrecombinants. Here, $R = 2$ and $NR = 18$, with $n = R + NR = 20$. The likelihood under a given $\\theta$ for these independent trials, ignoring the combinatorial factor that counts arrangements (which cancels in likelihood ratios when $R$ and $NR$ are fixed), is\n$$\nL(\\theta) \\propto \\theta^{R} (1 - \\theta)^{NR}.\n$$\nThe maximum-likelihood estimate $\\hat{\\theta}$ maximizes $L(\\theta)$ over $\\theta \\in [0,1]$. Equivalently, we maximize the log-likelihood\n$$\n\\ell(\\theta) = \\ln L(\\theta) = R \\ln \\theta + NR \\ln (1 - \\theta) + \\text{constant}.\n$$\nTaking the derivative with respect to $\\theta$ and setting it to zero,\n$$\n\\frac{d\\ell}{d\\theta} = \\frac{R}{\\theta} - \\frac{NR}{1 - \\theta} = 0\n\\quad \\Longrightarrow \\quad\n\\frac{R}{\\theta} = \\frac{NR}{1 - \\theta}\n\\quad \\Longrightarrow \\quad\nR(1 - \\theta) = NR \\theta\n\\quad \\Longrightarrow \\quad\nR = (R + NR)\\theta.\n$$\nTherefore,\n$$\n\\hat{\\theta} = \\frac{R}{R + NR} = \\frac{2}{20} = 0.1.\n$$\n\nThe logarithm of odds (LOD) score compares the likelihood under $\\theta$ to that under the no-linkage model, which has $\\theta = 0.5$. By definition,\n$$\nZ(\\theta) = \\log_{10}\\!\\left(\\frac{L(\\theta)}{L(0.5)}\\right)\n= \\log_{10}\\!\\left(\\frac{\\theta^{R}(1 - \\theta)^{NR}}{0.5^{R} 0.5^{NR}}\\right)\n= \\log_{10}\\!\\left(\\theta^{R}(1 - \\theta)^{NR}\\right) - \\log_{10}\\!\\left(0.5^{n}\\right).\n$$\nEvaluated at $\\hat{\\theta} = 0.1$ with $R = 2$, $NR = 18$, and $n = 20$,\n$$\nZ(\\hat{\\theta}) = \\log_{10}\\!\\left(0.1^{2} \\cdot 0.9^{18}\\right) - \\log_{10}\\!\\left(0.5^{20}\\right).\n$$\nCompute each term:\n$$\n\\log_{10}(0.1^{2}) = 2 \\log_{10}(0.1) = 2(-1) = -2,\n$$\n$$\n\\log_{10}(0.9^{18}) = 18 \\log_{10}(0.9) = 18(-0.04575749056\\ldots) \\approx -0.8236348301,\n$$\n$$\n\\log_{10}(0.5^{20}) = 20 \\log_{10}(0.5) = 20(-0.30102999566\\ldots) \\approx -6.020599913.\n$$\nTherefore,\n$$\nZ(\\hat{\\theta}) \\approx \\left[-2 + (-0.8236348301)\\right] - \\left[-6.020599913\\right]\n= -2.8236348301 + 6.020599913\n\\approx 3.196965083.\n$$\nRounded to four significant figures,\n$$\n\\hat{\\theta} = 0.1000, \\quad Z(\\hat{\\theta}) = 3.197.\n$$\n\nInterpretation of thresholds in linkage analysis:\n- The threshold $Z \\ge 3$ corresponds to odds of at least $10^{3}$ to $1$ in favor of linkage between the disease locus and the marker at the specified recombination fraction, which is conventionally taken as strong evidence of linkage and sufficient to declare genome-wide significant linkage in classical two-point or multipoint analyses, recognizing that replication or convergent evidence is still valuable in translational contexts.\n- The threshold $Z \\le -2$ corresponds to odds of at least $10^{2}$ to $1$ against linkage, which is typically taken as sufficient evidence to exclude linkage in the tested interval, guiding resource allocation away from that region for further translational investigation.\n\nUnder the assumptions stated, the data provide strong evidence for linkage between the disease locus and the marker, with an estimated genetic distance consistent with $\\hat{\\theta} = 0.1$ in the mapping population.", "answer": "$$\\boxed{\\begin{pmatrix}0.1000  3.197\\end{pmatrix}}$$", "id": "5021743"}, {"introduction": "While Mendelian principles provide a robust framework, clinical genetics is frequently confronted with exceptions and complex scenarios. This problem delves into one such critical area: uniparental disomy (UPD), where both copies of a chromosome originate from a single parent. You will synthesize principles of non-Mendelian inheritance, imprinting, and probability theory to calculate a patient's risk for both a recessive disorder and an imprinting disorder, a task that mirrors the complex risk assessments performed in modern genetic counseling. [@problem_id:5021727]", "problem": "A prenatal genetics clinic evaluates a fetus with evidence of trisomy rescue restricted to chromosome $15$ on chorionic villus sampling. The clinical team considers uniparental disomy (UPD), defined as the inheritance of both homologues of a chromosome from a single parent. UPD arises through meiotic nondisjunction and post-zygotic rescue and occurs in two forms: isodisomy (two copies of the same parental homologue) and heterodisomy (both different homologues from the same parent). The team is concerned about two classes of phenotypic risk tied to chromosome $15$: (i) an autosomal recessive disorder $D$ caused by a biallelic loss-of-function variant in a gene on chromosome $15$, and (ii) an imprinting disorder at a known chromosome $15$ imprinted domain, where the phenotype depends on parent-of-origin of the duplicated chromosome set.\n\nAssume the following, all conditional on the observed trisomy rescue for chromosome $15$ in this pregnancy:\n\n- The conditional probability of UPD for chromosome $15$ is $u = 0.12$.\n- Given UPD, the probability that it is isodisomy is $f = 0.25$ and heterodisomy is $1 - f$.\n- Given UPD, the probability of paternal origin is $r = 0.35$ and maternal origin is $1 - r$.\n- For the imprinting domain under consideration, paternal UPD leads to an imprinting phenotype with penetrance $s_{p} = 0.90$, and maternal UPD leads to an imprinting phenotype with penetrance $s_{m} = 0.95$.\n- For the autosomal recessive disorder $D$, the father is a confirmed heterozygous carrier at the causal locus (genotype $A/a$), and the mother is confirmed non-carrier (genotype $A/A$). The locus for $D$ lies on chromosome $15$, and there is no phenocopy. Homozygous $a/a$ has penetrance $1$.\n- When isodisomy arises from a heterozygous parent, assume that duplication is equally likely to involve either parental homologue at the locus of interest, so that if the parent is $A/a$, isodisomy yields $A/A$ or $a/a$ with equal probability $1/2$ at that locus. Assume that the imprinting domain is encompassed by the UPD segment regardless of isodisomy or heterodisomy.\n\nTasks:\n\n1. Using only fundamental Mendelian segregation principles and basic probability rules, briefly derive the expected genotype at the $D$ locus under paternal isodisomy versus paternal heterodisomy, and under maternal UPD, in this mating where the father is $A/a$ and the mother is $A/A$.\n2. Derive an analytic expression for the total probability that the child manifests any clinically apparent phenotype attributable to either the imprinting mechanism or the recessive disorder $D$ (counting co-occurrence only once, i.e., use the probability of the union of events).\n3. Evaluate this probability numerically using the parameter values above and express your final answer as a decimal. Round your answer to four significant figures.", "solution": "The problem statement is scientifically grounded, well-posed, objective, and internally consistent, providing all necessary parameters for a complete analysis. It is a valid problem in quantitative human genetics.\n\nThe solution is structured into three parts as requested by the problem statement. Let $P(\\text{event})$ denote the probability of an event. The entire analysis is conditional on the observation of trisomy rescue.\n\n**1. Genotype Derivations at the Disorder $D$ Locus**\n\nWe are given the parental genotypes for the disorder $D$ locus on chromosome $15$: the father is heterozygous ($A/a$) and the mother is homozygous normal ($A/A$).\n\n- **Paternal Isodisomy (patISO):** This form of uniparental disomy (UPD) involves the inheritance of two identical copies of a single paternal chromosome $15$. Since the father is heterozygous $A/a$, he possesses one chromosome bearing the $A$ allele and another bearing the $a$ allele. Isodisomy results from the duplication of one of these homologues. The problem specifies that either homologue is duplicated with equal probability. Therefore, the resulting fetal genotype will be $A/A$ with probability $\\frac{1}{2}$ or $a/a$ with probability $\\frac{1}{2}$. The $a/a$ genotype leads to the manifestation of disorder $D$.\n\n- **Paternal Heterodisomy (patHET):** This form of UPD involves the inheritance of both of the father's distinct chromosome $15$ homologues. As the father's genotype is $A/a$, the fetus inherits one chromosome with allele $A$ and one with allele $a$. The resulting fetal genotype is deterministically $A/a$. This genotype does not cause the recessive disorder $D$.\n\n- **Maternal Uniparental Disomy (matUPD):** This involves inheritance of both chromosome $15$s from the mother. The mother's genotype is $A/A$. Regardless of whether the mechanism is isodisomy (duplication of one maternal homologue) or heterodisomy (inheritance of both distinct maternal homologues), the only allele she can contribute is $A$. Therefore, any form of maternal UPD results in a fetal genotype of $A/A$, which does not cause disorder $D$.\n\nIn summary, the only scenario under which the fetus can have the $a/a$ genotype and thus be affected by disorder $D$ is paternal isodisomy.\n\n**2. Analytic Expression for Total Phenotype Probability**\n\nLet $\\text{Pheno}$ be the event that the child manifests any clinically apparent phenotype, either from the imprinting disorder (event $\\text{Pheno}_I$) or the recessive disorder $D$ (event $\\text{Pheno}_D$). We wish to find the total probability $P(\\text{Pheno}) = P(\\text{Pheno}_I \\cup \\text{Pheno}_D)$. Using the principle of inclusion-exclusion:\n$$P(\\text{Pheno}_I \\cup \\text{Pheno}_D) = P(\\text{Pheno}_I) + P(\\text{Pheno}_D) - P(\\text{Pheno}_I \\cap \\text{Pheno}_D)$$\nAll phenotypes are conditional on the occurrence of UPD, as biparental inheritance in this cross ($A/a \\times A/A$) does not produce an affected genotype ($a/a$) and does not cause an imprinting disorder. The overall probability of UPD is given as $u$. Thus, we can express all probabilities as being proportional to $u$.\n\n- **Probability of Recessive Disorder D, $P(\\text{Pheno}_D)$:**\nThe disorder $D$ occurs if the genotype is $a/a$. From part 1, this only happens under paternal isodisomy. The probability of this cascade of events is:\n$P(\\text{Pheno}_D) = P(\\text{UPD}) \\times P(\\text{paternal origin} | \\text{UPD}) \\times P(\\text{isodisomy} | \\text{UPD}) \\times P(\\text{genotype } a/a | \\text{patISO}) \\times P(\\text{phenotype} | a/a)$\nThe events of paternal origin and isodisomy are independent given UPD. Using the given parameters:\n- $P(\\text{UPD}) = u$\n- $P(\\text{paternal origin} | \\text{UPD}) = r$\n- $P(\\text{isodisomy} | \\text{UPD}) = f$\n- $P(\\text{genotype } a/a | \\text{patISO}) = \\frac{1}{2}$\n- Penetrance for $a/a$ is $1$.\nSo, $P(\\text{Pheno}_D) = u \\cdot r \\cdot f \\cdot \\frac{1}{2} \\cdot 1 = \\frac{1}{2}urf$.\n\n- **Probability of Imprinting Disorder, $P(\\text{Pheno}_I)$:**\nThe imprinting phenotype can arise from either paternal or maternal UPD, with different penetrances.\n$P(\\text{Pheno}_I) = P(\\text{Pheno}_I | \\text{paternal UPD})P(\\text{paternal UPD}) + P(\\text{Pheno}_I | \\text{maternal UPD})P(\\text{maternal UPD})$\nThe probability of paternal UPD is $P(\\text{UPD}) \\times P(\\text{paternal origin} | \\text{UPD}) = ur$.\nThe probability of maternal UPD is $P(\\text{UPD}) \\times P(\\text{maternal origin} | \\text{UPD}) = u(1-r)$.\nThe probabilities of phenotype given the origin are the penetrances $s_p$ and $s_m$.\n$P(\\text{Pheno}_I) = s_p \\cdot (ur) + s_m \\cdot u(1-r) = u(s_p r + s_m(1-r))$.\n\n- **Probability of Intersection, $P(\\text{Pheno}_I \\cap \\text{Pheno}_D)$:**\nBoth phenotypes occur if the fetus has genotype $a/a$ (causing $\\text{Pheno}_D$) AND the imprinting disorder manifests (causing $\\text{Pheno}_I$). The $a/a$ genotype requires paternal isodisomy. The imprinting disorder can occur with any paternal UPD, including isodisomy, with penetrance $s_p$. The intersection event thus requires paternal isodisomy, the $a/a$ genotype, and the manifestation of the imprinting phenotype.\n$P(\\text{Pheno}_I \\cap \\text{Pheno}_D) = P(\\text{UPD}) \\times P(\\text{paternal origin} | \\text{UPD}) \\times P(\\text{isodisomy} | \\text{UPD}) \\times P(a/a | \\text{patISO}) \\times P(\\text{imprinting phenotype} | \\text{patISO})$\nAssuming the penetrance of the imprinting disorder is independent of the allelic state at the $D$ locus, $P(\\text{imprinting phenotype} | \\text{patISO}) = s_p$.\n$P(\\text{Pheno}_I \\cap \\text{Pheno}_D) = u \\cdot r \\cdot f \\cdot \\frac{1}{2} \\cdot s_p = \\frac{1}{2}urfs_p$.\n\n- **Total Probability of Any Phenotype:**\nSubstituting these terms back into the inclusion-exclusion formula:\n$P(\\text{Pheno}) = u(s_p r + s_m(1-r)) + \\frac{1}{2}urf - \\frac{1}{2}urfs_p$\nFactoring out common terms gives the final analytic expression:\n$$P(\\text{Pheno}) = u \\left[ s_p r + s_m(1-r) + \\frac{1}{2}rf(1-s_p) \\right]$$\n\n**3. Numerical Evaluation**\n\nWe substitute the given numerical values into the derived expression:\n- $u = 0.12$\n- $r = 0.35$\n- $f = 0.25$\n- $s_p = 0.90$\n- $s_m = 0.95$\n\nFirst, calculate the terms inside the brackets:\n- $s_p r = (0.90)(0.35) = 0.315$\n- $s_m(1-r) = (0.95)(1 - 0.35) = (0.95)(0.65) = 0.6175$\n- $\\frac{1}{2}rf(1-s_p) = \\frac{1}{2}(0.35)(0.25)(1 - 0.90) = (0.5)(0.35)(0.25)(0.10) = 0.004375$\n\nSumming these terms:\n$$ \\text{Bracket term} = 0.315 + 0.6175 + 0.004375 = 0.936875 $$\n\nFinally, multiply by the probability of UPD, $u$:\n$$ P(\\text{Pheno}) = 0.12 \\times 0.936875 = 0.112425 $$\n\nRounding to four significant figures, the total probability that the child manifests any clinically apparent phenotype is $0.1124$.", "answer": "$$\\boxed{0.1124}$$", "id": "5021727"}]}